Home/Filings/4/0000950170-25-024487
4//SEC Filing

Moran Kevin Patrick 4

Accession 0000950170-25-024487

CIK 0001347178other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 7:44 PM ET

Size

5.7 KB

Accession

0000950170-25-024487

Insider Transaction Report

Form 4
Period: 2025-02-18
Moran Kevin Patrick
SVP, CFO & Treasurer
Transactions
  • Award

    Common Stock

    2025-02-18+125,000353,763 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    635
Footnotes (1)
  • [F1]Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2026, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.

Documents

1 file

Issuer

Vanda Pharmaceuticals Inc.

CIK 0001347178

Entity typeother

Related Parties

1
  • filerCIK 0001806596

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 7:44 PM ET
Size
5.7 KB